Dr. Gladstone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
University of RochesterResidency, Internal Medicine, 1992 - 1996
New York University School of MedicineClass of 1992
Certifications & Licensure
NY State Medical License 1993 - 2026
MD State Medical License 1996 - 2022
NC State Medical License 2020 - 2022
ME State Medical License 2020 - 2021
PA State Medical License 1999 - 2004
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Phase II High-Dose Cyclophosphamide for Multiple Sclerosis Start of enrollment: 2003 Oct 01
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies Start of enrollment: 2014 Mar 13
- Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies Start of enrollment: 2018 Jul 31
- Join now to see all
Publications & Presentations
PubMed
- 46 citationsMoxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Tadeusz Robak
Journal of Hematology & Oncology. 2021-02-24 - 52 citationsHLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunitiesDouglas E. Gladstone, Maria Bettinotti
Hematology. American Society of Hematology. Education Program. 2017-12-08 - 91 citationsPartially Mismatched Transplantation and Human Leukocyte Antigen Donor-Specific AntibodiesDouglas E. Gladstone, Andrea A. Zachary, Ephraim J. Fuchs, Leo Luznik, Yvette L. Kasamon
Biology of Blood and Marrow Transplantation. 2013-04-01
Abstracts/Posters
- Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume LeukapheresisDouglas E Gladstone, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 PatientsDouglas E Gladstone, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Ongoing Results of a Phase 1B/2 Dose-Escalation and Cohort-Expansion Study of the Selective, Noncovalent, Reversible BrutonÍS Tyrosine Kinase Inhibitor, Vecabrutinib, ...Douglas E Gladstone, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/douglas-gladstone
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
